Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-15 5:05 pm Purchase |
2025-03-31 | 13G | Maze Therapeutics, Inc. MAZE |
ARCH Venture Fund X, L.P. | 4,120,053 9.400% |
4,120,053 (New Position) |
Filing History |
| 2025-05-14 4:10 pm Purchase |
2025-03-31 | 13G | Maze Therapeutics, Inc. MAZE |
Matrix Capital Management Company LP | 2,486,184 5.700% |
2,486,184 (New Position) |
Filing History |
| 2025-05-14 11:48 am Purchase |
2025-03-31 | 13G | Maze Therapeutics, Inc. MAZE |
JANUS HENDERSON GROUP PLC JHG |
2,498,111 5.700% |
2,498,111 (New Position) |
Filing History |
| 2025-05-09 4:15 pm Purchase |
2025-03-31 | 13G | Maze Therapeutics, Inc. MAZE |
GV 2019, L.P. | 2,412,471 5.500% |
2,412,471 (New Position) |
Filing History |
| 2025-05-09 4:15 pm Purchase |
2025-01-31 | 13G | Maze Therapeutics, Inc. MAZE |
Third Rock Ventures IV, L.P. | 6,073,958 13.900% |
6,073,958 (New Position) |
Filing History |
| 2025-04-29 09:59 am Purchase |
2025-04-25 | 13G | Maze Therapeutics, Inc. MAZE |
Frazier Life Sciences Public Fund, L.P. | 4,451,339 10.200% |
322,339 (+7.81%) |
Filing History |
| 2025-04-29 09:58 am Purchase |
2025-03-31 | 13G | Maze Therapeutics, Inc. MAZE |
Frazier Life Sciences Public Fund, L.P. | 4,129,000 9.400% |
935,100 (+29.28%) |
Filing History |
| 2025-02-10 10:55 am Purchase |
2025-02-03 | 13G | Maze Therapeutics, Inc. MAZE |
Frazier Life Sciences Public Fund, L.P. | 3,193,900 7.300% |
3,193,900 (New Position) |
Filing History |
| 2025-02-07 4:30 pm Purchase |
2025-01-31 | 13G | Maze Therapeutics, Inc. MAZE |
Deep Track Capital, LP | 3,023,484 6.910% |
3,023,484 (New Position) |
Filing History |
| 2025-02-07 4:01 pm Unchanged |
2025-01-31 | 13G | Maze Therapeutics, Inc. MAZE |
Foresite Capital Fund IV, L.P. | 2,457,108 5.600% |
0 (Unchanged) |
Filing History |
| 2025-02-07 4:01 pm Purchase |
2025-01-31 | 13G | Maze Therapeutics, Inc. MAZE |
Foresite Capital Fund IV, L.P. | 2,457,108 5.600% |
2,457,108 (New Position) |
Filing History |